Literature DB >> 16824039

Measles virus induces expression of SIP110, a constitutively membrane clustered lipid phosphatase, which inhibits T cell proliferation.

Elita Avota1, Harry Harms, Sibylle Schneider-Schaulies.   

Abstract

Interference of measles virus (MV) with phosphatidyl-inositol-3-kinase (PI3K) activation in response to T cell receptor ligation was identified as important for the induction of T cell paralysis. We now show that MV exposure of unstimulated T cells induces expression of SIP110, an isoform of the lipid phosphatase SHIP145, which is translated from an intron-derived sequences containing mRNA. We found that MV contact can regulate stimulated exon inclusion into pre-mRNAs by targeting PI3K or MAPK-dependent nuclear translocation and activation of splicing regulatory serine-arginine rich (SR) and Sam68 proteins. Induction of SIP110 in resting T cells relied on MV-dependent interference with basal activity of the PI3K. SIP110 was cloned from MV-exposed T cells, and, when transiently expressed in primary or Jurkat T cells, localized into membrane clusters independently of T cell activation. Confirming that SIP110 is a catalytically active lipid phosphatase, its transgenic expression abolished basal and impaired PMA/ionomycin-stimulated phosphorylation of the Akt kinase which is important for T cell proliferation. Thus MV causes induction of SIP110 expression, which constitutively depletes the cellular phosphoinositol-3,4,5-phosphate pool suggesting that thereby the threshold for activation signals necessary for the induction of T cell proliferation is raised.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16824039     DOI: 10.1111/j.1462-5822.2006.00752.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  16 in total

Review 1.  Viral modulation of T-cell receptor signaling.

Authors:  Keith R Jerome
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

2.  Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer.

Authors:  Gwenny M Fuhler; Robert Brooks; Bonnie Toms; Sonia Iyer; Elizabeth A Gengo; Mi-Young Park; Matthew Gumbleton; Dennis R Viernes; John D Chisholm; William G Kerr
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

3.  Dominant inhibition of Akt/protein kinase B signaling by the matrix protein of a negative-strand RNA virus.

Authors:  Ewan F Dunn; John H Connor
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

Review 4.  Measles virus-induced immunosuppression: from effectors to mechanisms.

Authors:  Elita Avota; Evelyn Gassert; Sibylle Schneider-Schaulies
Journal:  Med Microbiol Immunol       Date:  2010-04-08       Impact factor: 3.402

Review 5.  Measles virus-induced suppression of immune responses.

Authors:  Diane E Griffin
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

6.  Screening of candidate genes associated with high titer production of oncolytic measles virus based on systems biology approach.

Authors:  Malihe Rastegarpanah; Kayhan Azadmanesh; Babak Negahdari; Yazdan Asgari; Mohammadali Mazloomi
Journal:  Virus Genes       Date:  2022-04-27       Impact factor: 2.332

7.  Measles virus-induced block of transendothelial migration of T lymphocytes and infection-mediated virus spread across endothelial cell barriers.

Authors:  Sandra Dittmar; Harry Harms; Nicole Runkler; Andrea Maisner; Kwang Sik Kim; Jürgen Schneider-Schaulies
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

8.  Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus.

Authors:  T Rothoeft; K Fischer; S Zawatzki; V Schulz; U Schauer; C Körner Rettberg
Journal:  Clin Exp Immunol       Date:  2007-09-24       Impact factor: 4.330

9.  Induction of membrane ceramides: a novel strategy to interfere with T lymphocyte cytoskeletal reorganisation in viral immunosuppression.

Authors:  Evelyn Gassert; Elita Avota; Harry Harms; Georg Krohne; Erich Gulbins; Sibylle Schneider-Schaulies
Journal:  PLoS Pathog       Date:  2009-10-16       Impact factor: 6.823

10.  Accumulation of splice variants and transcripts in response to PI3K inhibition in T cells.

Authors:  Alice Riedel; Boitumelo Mofolo; Elita Avota; Sibylle Schneider-Schaulies; Ayton Meintjes; Nicola Mulder; Susanne Kneitz
Journal:  PLoS One       Date:  2013-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.